References
Markman M (2003) Managing taxane toxicities. Support Care Cancer 11:144–147
Kautio AL, Haanpaa M, Kautiainen H, Kalso E, Saarto T (2011) Burden of chemotherapy-induced neuropathy—a cross-sectional study. Support Care Cancer 19:1991–1996
Rowinsky EK, Onetto N, Canetta RM, Arbuck SG (1992) Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol 19:646–662
Webster LK, Crinis NA, Morton CG, Millward MJ (1996) Plasma alcohol concentrations in patients following paclitaxel infusion. Cancer Chemother Pharmocol 37:499–501
Meng S, Su B, Li W, Ding Y, Tang L, Zhou W, Song Y, Caicun Z (2011) Integrin-targeted paclitaxel nanoliposomes for tumor therapy. Med Oncol 28:1180–1187
Acknowledgments
Supported by the Research Project of the Ministry of Health of the Czech Republic No. 00179906 and the Specific University Research of Charles University in Prague No. 53251.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Slovacek, L., Slovackova, B. Drug-induced hallucinatory syndrome in a patient with breast cancer after paclitaxel infusion. Support Care Cancer 20, 1931–1933 (2012). https://doi.org/10.1007/s00520-012-1438-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-012-1438-3